Sands Capital Management - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 141 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Sands Capital Management ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q1 2022$79,264,000
-46.6%
4,189,421
-1.0%
0.18%
-34.1%
Q4 2021$148,505,000
-3.2%
4,233,337
+1.0%
0.28%
+7.8%
Q3 2021$153,376,000
-4.5%
4,189,453
+2.5%
0.26%
-5.9%
Q2 2021$160,554,000
+42.1%
4,088,471
+2.2%
0.27%
+24.8%
Q1 2021$112,960,000
-50.0%
3,998,599
-43.3%
0.22%
+1.4%
Q4 2020$225,802,000
+113.7%
7,051,916
+115.5%
0.22%
-6.1%
Q3 2020$105,687,000
+53.2%
3,272,034
+30.8%
0.23%
+37.1%
Q2 2020$69,004,000
+63.0%
2,501,976
+5.5%
0.17%
+18.4%
Q1 2020$42,339,000
+12.1%
2,371,925
+57.4%
0.14%
+28.2%
Q4 2019$37,770,000
+136.2%
1,506,575
+68.1%
0.11%
+115.7%
Q3 2019$15,991,000
-16.2%
896,370
+3.3%
0.05%
-10.5%
Q2 2019$19,093,000
-23.6%
867,873
+6.2%
0.06%
-26.0%
Q1 2019$24,984,000
+30.3%
816,991
-1.6%
0.08%
+13.2%
Q4 2018$19,177,000
+17.2%
830,520
+63.4%
0.07%
+47.8%
Q3 2018$16,361,000508,2750.05%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q3 2021
NameSharesValueWeighting ↓
Zeal Asset Management Ltd 421,140$5,075,00010.46%
Capital International, Inc./CA/ 4,151,900$52,480,0000.73%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 859$68,000,0000.71%
GENERAL ATLANTIC, L.P. 4,000,000$50,560,0000.66%
Capital International Sarl 544,653$6,884,0000.55%
M&G INVESTMENT MANAGEMENT LTD 6,977,228$90,704,0000.54%
E Fund Management (Hong Kong) Co., Ltd. 58,861$744,0000.51%
Bellevue Group AG 1,756,307$21,359,0000.30%
AIA Group Ltd 356,640$4,508,0000.24%
PLATINUM INVESTMENT MANAGEMENT LTD 224,634$2,839,0000.11%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders